Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NASDAQ:ONVO)

3.10
Delayed Data
As of Mar 27
 +0.07 / +2.31%
Today’s Change
2.01
Today|||52-Week Range
4.99
-8.55%
Year-to-Date
No recent news for Organovo Holdings Inc.

Today’s Trading

Previous close3.03
Today’s open3.00
Day’s range2.94 - 3.15
Volume979,153
Average volume (3 months)1,386,372
Market cap$316.4M
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+8.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book4.50

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.11+3.05%
VYGRVoyager Therapeutics...+0.57+4.93%
BLCMBellicum Pharmaceuti...+0.14+1.16%
PDLIPDL BioPharma Inc+0.07+3.54%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateJune 15, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Keith Murphy
Chief Financial Officer
Craig S. Kussman
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs